PAVmed Series Return On Equity vs. Revenue
| PAVMZ Stock | USD 0.03 0.00 0.00% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 1.19215694 | Current Value 1.13 | Quarterly Volatility 7.6769636 |
For PAVmed Series profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PAVmed Series to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PAVmed Series Z utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PAVmed Series's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PAVmed Series Z over time as well as its relative position and ranking within its peers.
PAVmed |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed Series. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed Series listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Series Z is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed Series' value that differs from its market value or its book value, called intrinsic value, which is PAVmed Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed Series' market value can be influenced by many factors that don't directly affect PAVmed Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PAVmed Series Z Revenue vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PAVmed Series's current stock value. Our valuation model uses many indicators to compare PAVmed Series value to that of its competitors to determine the firm's financial worth. PAVmed Series Z is considered to be number one stock in return on equity category among its peers. It also is rated top company in revenue category among its peers . At this time, PAVmed Series' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PAVmed Series' earnings, one of the primary drivers of an investment's value.PAVmed Revenue vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
PAVmed Series |
| = | -13.58 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
PAVmed Series |
| = | 2.45 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
PAVmed Revenue vs Competition
PAVmed Series Z is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 53.47 Billion. PAVmed Series adds roughly 2.45 Million in revenue claiming only tiny portion of equities under Health Care industry.
PAVmed Series Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in PAVmed Series, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PAVmed Series will eventually generate negative long term returns. The profitability progress is the general direction of PAVmed Series' change in net profit over the period of time. It can combine multiple indicators of PAVmed Series, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3 B | -2.8 B | |
| Operating Income | -68.8 M | -65.4 M | |
| Income Before Tax | -79.3 M | -75.3 M | |
| Net Loss | -31.1 M | -29.6 M | |
| Net Loss | -64.2 M | -61 M | |
| Total Other Income Expense Net | -10.5 M | -9.9 M | |
| Net Interest Income | -448 K | -470.4 K | |
| Interest Income | 505 K | 479.8 K | |
| Net Loss | -86.4 M | -82.1 M | |
| Income Tax Expense | -13 B | -12.3 B | |
| Non Operating Income Net Other | -11.3 M | -11.8 M | |
| Change To Netincome | 1.8 M | 1.6 M | |
| Net Loss | (8.87) | (9.32) | |
| Income Quality | 0.81 | 0.51 | |
| Net Income Per E B T | 0.81 | 1.02 |
PAVmed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PAVmed Series. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PAVmed Series position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PAVmed Series' important profitability drivers and their relationship over time.
Use PAVmed Series in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PAVmed Series position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PAVmed Series will appreciate offsetting losses from the drop in the long position's value.PAVmed Series Pair Trading
PAVmed Series Z Pair Trading Analysis
The ability to find closely correlated positions to PAVmed Series could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PAVmed Series when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PAVmed Series - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PAVmed Series Z to buy it.
The correlation of PAVmed Series is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PAVmed Series moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PAVmed Series Z moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PAVmed Series can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your PAVmed Series position
In addition to having PAVmed Series in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.